Monday Apr 29
Growing problem of drug-resistant gonorrhea prompts treatment changes in Ontario
Faced with evidence that drug-resistant gonorrhea is spreading in the province, Ontario is recommending a different treatment approach for the sexually transmitted infection.
Fri Apr 26, 2013
Lupin voluntarily recalls anti-infectious drug from US market
Pharma major Lupin is voluntarily recalling some lots of Suprax, which is used to treat common infections, from the US market on account of discolouration, according to US Food and Drug Administration .
Tue Feb 26, 2013
Lupin Receives FDA Approval For New Drug Application For SUPRAX Oral Suspension, 500 Mg/5mL
Approval to add to growing SUPRAX Franchise Pharma major, Lupin Ltd., announced last week that its subsidiary, Lupin Pharmaceuticals Inc.
Sat Feb 23, 2013
Lupin receives FDA nod for SUPRAX oral suspension
Mumbai/Baltimore, Feb 23 : Pharma major Lupin Ltd. announced that its subsidiary Lupin Pharmaceuticals Inc.
Fri Feb 22, 2013
Lupin receives USFDA nod for Suprax oral suspension
Drug firm Lupin today said it has received approval from the US health regulator for its Suprax oral suspension used for treating bacterial infections and expects to commence shipping the product in the near future.